Search Videos and More

Showing 1 - 12 of 192 results

Previous| 1 | 2 | 3 ...16 |Next


AUA 2025 Speaker and Poster Sessions News

AUA 2025 Speaker and Poster Sessions

Visit the Fox Chase-Temple Urologic Institute Booth #2253 in the Science & Technology Hall (Expo Halls A,B,C).
Complex Patient Case Review for Oncologic and Benign Urology Course

Complex Patient Case Review for Oncologic and Benign Urology

Live Webinar | 5:00 PM - 6:00 PM EDT | Wednesday, May 21, 2025
Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds News

Local Excision Possible for More Rectal Cancer Patients, Fox Chase Cancer Center Study Finds

Results from a study presented by Fox Chase Cancer Center researchers at the Society of Surgical Oncology 2025 Annual Meeting suggest that chemotherapy followed by local excision is a promising treatment option for patients with node-negative low rectal cancer.
Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer News

Fox Chase Cancer Center Study Shows That Examining More Lymph Nodes Was Associated With Improved Outcomes for Patients With Colon Cancer

Removing and testing at least 18 lymph nodes during surgery was associated with more accurate staging and better survival rates for colon cancer patients, according to research presented today at the Society of Surgical Oncology 2025 Annual Meeting. The findings from researchers at Fox Chase Cancer Center challenge the current standard of care for staging colon cancer, which calls for removal and examination of 12 lymph nodes.
INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy News

INSITE Trial Looking to Identify Which Patients Can Forgo Cystectomy

Alexander Kutikov, MD, FACS, and Matthew R. Zibelman, MD, are conducting a new trial called INSITE to attempt to answer that question.
ASCO Genitourinary Cancer Symposium 2025: Fox Chase Advances Cancer Prevention, Research, and Potential Cures News

ASCO Genitourinary Cancer Symposium 2025: Fox Chase Advances Cancer Prevention, Research, and Potential Cures

This year, Fox Chase faculty and Fellows presented research that revealed tangible benefits for genitourinary cancer patient outcomes and quality of life.
Monthly Multi-Institutional Hematopathology Interesting Case Conference Course

Monthly Multi-Institutional Hematopathology Interesting Case Conference

Please join us for our next Monthly Multi-Institutonal Hematopathology Interesting Case Conference (MHICC). A collaborative meeting that brings together pathologists, clinicians and researchers from renowned institutions to discuss challenging and educational hematopathology cases
A tragic death becomes a life force. News

A tragic death becomes a life force.

“A defining moment in my life was when my father was diagnosed with glioblastoma. At the time, we lived in New York’s Hudson Valley, and no area medical center offered treatment for a serious and complicated diagnosis like his. The only available therapy was in Manhattan, so at age 16, with just a learner’s permit, I drove my dad into the city to fight for his life while I maneuvered the George Washington Bridge as a novice driver,” says James P. Nitzkorski, MD, FACS, FSSO, a former Surgical Oncology Fellow at Fox Chase Cancer Center, and now, a surgical oncologist at Nuvance Health and Program Director for the General Surgery Residency at Vassar Brothers Medical Center, both in Poughkeepsie, NY. His father’s experience p
Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies Symposium

Optimizing Treatment Strategies for Localized and Advanced Genitourinary Malignancies

The management of advanced kidney, bladder, and prostate cancer is rapidly evolving, and new robotic and minimally invasive surgical techniques are now available. Presented by the nationally recognized Fox Chase Cancer Center genitourinary oncology team—comprising experts in urology, radiation therapy, and medical oncology—this program will cover the latest advancements in surgical techniques, radiation therapies, and medical treatments for both localized and advanced bladder, kidney, and prostate cancers.
Jay Simhan, MD, FACS Named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University News

Jay Simhan, MD, FACS Named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University

Jay Simhan, MD, FACS, has been named Chair of the Department of Urology at Temple University Hospital and the Lewis Katz School of Medicine at Temple University.
Preventing Lymphedema Right from the Start:<br><sub>Using Advanced Microsurgery During Cancer Surgery</sub> News

Preventing Lymphedema Right from the Start:
Using Advanced Microsurgery During Cancer Surgery

For many breast cancer patients, lymphedema is a feared side effect that causes life-disrupting symptoms, including fluid buildup, inflammation, pain, infection, and swelling that can bring arms or legs to three to four times their normal size.
The Hoofbeats You Hear May Be a Zebra: Cancer Diagnoses in Ages 18 to 39 News

The Hoofbeats You Hear May Be a Zebra: Cancer Diagnoses in Ages 18 to 39

At Fox Chase, the Young Adult Cancer Program has been developed as a comprehensive, robust resource to help young adults and their doctors face the challenges of cancer just as someone begins to navigate life’s milestones—finishing school, beginning careers, attaining financial stability, and starting families. It’s a clinical and a psychosocial maelstrom.

Showing 1 - 12 of 192 results

Previous| 1 | 2 | 3 ...16 |Next